https://www.selleckchem.com/pr....oducts/dimethindene-
72 events/h vs -9 events/h) but the difference was not significant at 12 months, though 28% of patients from the IG had an AHI less then 30 events/h compared to none in the CG (p=0.046). At 12 months, the IG showed a reduction in C-reactive protein (p=0.013), glycated hemoglobin (p=0.031) and an increase in high density lipoprotein cholesterol (p=0.027). CONCLUSIONS An IWLP in patients with obesity and severe OSA is effective for reducing weight and OSA severity. It also results in an improvement in lipid profiles, glycemic